Related Experiment Video
Updated: Jun 19, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Advances in the Multimodality Imaging and Management of Recurrent Pericarditis: A Contemporary Review
Harsha Sanaka1, Elio Haroun2, Aro Daniela Arockiam2
1Biomedical Science Undergraduate Program, The Ohio State University College of Medicine, Columbus, OH, 43210, USA.
Purpose Of Review:
To outline recent advances in imaging and treatment for recurrent pericarditis (RP).
Recent Findings:
Greater understanding of NLRP3 inflammasome activation in the pathogenesis of RP has led to the development of several anti-interleukin (IL-1) agents, and technological advancements have increased the utility of multimodality imaging in RP. Multimodality imaging plays a crucial role in the assessment of RP, with echocardiography serving as the initial imaging modality; cardiac magnetic resonance (CMR) as a pivotal test for diagnosis, grading severity, and surveillance; and cardiac computed tomography (CT) providing complimentary information and assisting operative assessment. Anti-IL-1 agents are now well-established as second line therapy for RP, with recent clinical trials demonstrating their efficacy.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management

